ME Conferences is overwhelmed to announce the commencement of “WORLD NEONATAL, PEDIATRICS AND FAMILY MEDICINE CONFERENCE 2019” going to be held during March 21-22, 2019 at Dubai, UAE with the innovative theme “Leading medications and essential care of Neotrics”. This innovative conference discusses the directions for Paediatric Nutrition, surgery and neonatal care with advanced medical and family medicine in this fast moving and developing science and technology. World Conference on Faneotrics: neonatology and paediatrics provides the scope for opportunities to learn about latest technologies, medical practices and mainly focuses on spreading the awareness about how to prevent neonatal and paediatric diseases and various challenges in the field of neonatology and pediatrics. The objective is to gather audience from everywhere throughout the world to present current research and to disseminate the new trends in the field of Paediatrics, Neonatology and Family medicine.
Fuji’s AstaReal and NUTRESSENT enter into Collaborative Partnership to develop new innovations in Astaxanthin ROS Scavenger formulations
Pune : In one of the most unique collaborations in the nutraceutical industry, Japanese company AstaReal, a subsidiary of Fuji Chemical Group has entered a collaborative partnership with Indian company Transcend Nutressential International Ltd (NUTRESSENT), a nutraceutical company focused on wellness through responsible nutrition. This partnership will enable NUTRESSENT to focus on new formulations and […]
New Delhi, 14th May 2018: Patients with an irregular heart rhythm, which puts them at a higher risk for stroke, still need treatment even after their heart rhythm seems to have returned to normal, according to a recent study. People with atrial fibrillation (AF) are much more likely to develop blood clots and suffer from […]
New York, New York (webnewswire) April 11, 2018 – Created by Paradigm Spine, LLC, coflex® is the first and only motion preserving treatment for moderate to severe spinal stenosis that is minimally invasive. This Interlaminar Stabilization® device is indicated for use in one or two level lumbar stenosis from L1-L5 in skeletally mature patients with […]